GAITHERSBURG, Md.--(BUSINESS WIRE)--Jan 6, 2026--
GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights today announced Linda Genen, MD, MPH as Chief Medical Officer to further strengthen the company’s commitment to delivering earlier answers and better outcomes for families through genomic insights.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260106493899/en/
In her role at GeneDx, Dr. Genen will oversee Medical and Clinical Affairs, lead the company’s clinical strategy, and champion adoption of genomic medicine across health systems, payers, policymakers, and the broader medical community. She will work closely with GeneDx’s executive team to accelerate integration of genomics into routine care and ensure that families everywhere benefit from earlier diagnosis and intervention. Dr. Genen will also help shape the company’s real-world evidence initiatives, guide payer engagement, and partner closely across GeneDx’s innovation, commercial, and policy teams to advance adoption of genomic medicine at scale.
Dr. Genen brings decades of leadership across clinical practice, payer strategy, innovation, and maternal-infant health. A former neonatologist and healthcare executive, she joins GeneDx from ProgenyHealth, a leading national, tech-enabled women's healthcare company dedicated to maternity and NICU care management, where she served as Chief Medical Officer and led clinical strategy, analytics, and quality programs that improved outcomes for mothers and infants across diverse populations.
“When used early, genomics has the potential to fundamentally transform healthcare, but today this technology is used too sparingly and too late, leading to unnecessary disease progression, suffering and increased costs. We’re going to change that,” said Katherine Stueland, President and CEO of GeneDx. “Dr. Genen has a passion for how genomics can and should be used to improve health outcomes for everyone. Her deep clinical experience, payer expertise, and proven ability to drive innovation at scale make her uniquely equipped to help lead the next chapter of genomic adoption and patient impact. By incorporating exome and genome testing at the earliest moment possible, we can transform our approach to healthcare.”
Dr. Genen previously held senior leadership roles at UnitedHealth Group and Optum, where she developed and scaled innovative models in women’s health, digital care delivery, and maternal-infant medicine. Earlier in her career, she served as a practicing neonatologist at Northwell’s Cohen Children’s Hospital and Assistant Professor of Pediatrics at Hofstra University. She currently serves on the board of Hera Women’s Health and is a Distinguished Mentor in Stanford University’s Clinical Informatics Management program.
“With nearly one million sequenced genomes and exomes and the largest rare disease dataset in the field, GeneDx is redefining what’s possible in genomic medicine – diagnosing rare disease earlier and accelerating breakthrough discovery – while shaping the future of lifelong precision health,” said Dr. Genen. “Families deserve fast, accurate answers and equitable access to genomic innovation. I’m honored to join a mission-driven team leading the future of patient care and making genomics foundational to everyday healthcare.”
About GeneDx
GeneDx (Nasdaq: WGS) is the global leader in rare disease diagnosis, with a mission to empower everyone to live their healthiest life through genomics. GeneDx combines unmatched clinical expertise, advanced technology, and the power of GeneDx Infinity™ – the world’s largest rare disease genomic dataset. This unparalleled foundation powers GeneDx’s ExomeDx™ and GenomeDx™ tests – ranked #1 by expert geneticists and granted FDA Breakthrough Device designation – enabling clinicians to deliver precise, fast, and actionable diagnoses. GeneDx Infinity also fuels discovery for biopharma with the most powerful AI-driven genomic intelligence. A genomics pioneer over the last 25 years, diagnosing more than 4,800 genetic diseases and publishing more than 1,000 research publications, GeneDx is building the network that will drive the future of genomic precision medicine. For more information, visit genedx.com and connect with us on LinkedIn, Facebook, and Instagram.
Forward Looking Statements
This press release may contain “forward-looking statements” within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements generally are identified by the words “believe,” “project,” “expect,” “anticipate,” “estimate,” “intend,” “strategy,” “future,” “opportunity,” “plan,” “may,” “should,” “will,” “would,” “will be,” “will continue,” “will likely result,” and similar expressions. Forward-looking statements are predictions, projections and other statements about future events that are based on current expectations and assumptions and, as a result, are subject to risks and uncertainties. Many factors could cause actual future events to differ materially from the forward-looking statements in this press release, including but not limited to: (i) our ability to implement plans to accelerate and unlock the full potential of precision medicine, (ii) the risk of downturns and a changing regulatory landscape in the highly competitive healthcare industry, (iii) the size and growth of the market in which we operate, (iv) our ability to pursue our new strategic direction. The foregoing list of factors is not exhaustive. A further list and description of risks, uncertainties and other matters can be found in the “Risk Factors” section of our Annual Report on Form 10-K for the fiscal year ended December 31, 2024 and our Quarterly Reports on Form 10-Q for the fiscal quarters ended March 31, 2025 and June 30, 2025, and other documents filed by us from time to time with the SEC. These filings identify and address other important risks and uncertainties that could cause actual events and results to differ materially from those contained in the forward-looking statements. Forward-looking statements speak only as of the date they are made. Readers are cautioned not to put undue reliance on forward-looking statements, and we assume no obligation and do not intend to update or revise these forward-looking statements, whether as a result of new information, future events, or otherwise. We do not give any assurance that we will achieve our expectations.
GeneDx Names Dr. Linda Genen, MD, MPH as Chief Medical Officer
The 2025 NFL season was dominated by first-round quarterbacks with old veterans like Matthew Stafford and a new generation featuring Drake Maye and Caleb Williams taking center stage.
The playoffs should be no different with a record-tying 12 of the 14 teams that qualified for the postseason set to use a first-round pick as their starting quarterback. The only year in the Super Bowl era with two or fewer non-first-round QBs starting a playoff game came in 2024 when Jalen Hurts and Russell Wilson did it.
The NFL set a record this season with 219 of the 272 games won by a quarterback who was drafted in round one, besting the mark of 204 set the previous year.
And the record isn't about a longer season or more teams as the 80.5% of games won by a first-round quarterback was easily the highest since the start of the common draft in 1967. The only other season with more than 70% of games won by a first-round QB came in 2024 when the rate was 75%.
The rate was less than half of games as recently as 2008 and down at 23% in 2001, when Tom Brady first became a starter in New England a year after being a sixth-round pick.
The only outlier will be the wild-card game on Sunday in Philadelphia when San Francisco’s former seventh-round pick Brock Purdy takes on former second-rounder Hurts and the Eagles.
Those teams have shown there is an alternate path to success as Hurts and Purdy have represented the NFC in the last three Super Bowls. But unless the winner of that game also wins the divisional round, this season will join the 2010 season as the only ones in the Super Bowl era with all four starting QBs in the conference title game being first-rounders.
This postseason will feature four quarterbacks picked first overall with Stafford and Carolina's Bryce Young facing off in the 13th playoff matchup of No. 1 pick quarterbacks in the Super Bowl era. Williams and Jacksonville's Trevor Lawrence are the other two top picks.
There were five others picked in the top 10, including 2024 No. 3 pick Maye and 2018 No. 7 pick Josh Allen of Buffalo. Houston's C.J. Stroud went second in 2023, while Sam Darnold was picked third by the Jets in 2018 and Justin Herbert went sixth to the Chargers in 2020.
Three others went later in the first with Denver's Bo Nix going 12th in 2024 and two QBs picked by Green Bay: Aaron Rodgers at No. 24 in 2005 and Jordan Love at No. 26 in 2020.
Then there's Hurts at No. 53 in 2020 and Purdy, who was Mr. Irrelevant as the 262nd and final pick of the 2022 draft.
Myles Garrett set the single-season sack record with 23, while several other league leaders also had some noteworthy performances.
Stafford led the NFL with 46 touchdown passes and 4,707 yards passing, while throwing only eight interceptions for the Los Angeles Rams. Stafford joined Brady in his record-setting 2007 season as the only players to lead the league in TD passes and yards while throwing eight or fewer interceptions.
Maye, who is second in AP NFL MVP odds at BetMGM to Stafford, became the seventh player to throw for at least 4,000 yards and 30 TDs in a season before turning 24 and the first to do it with fewer than 10 interceptions.
Maye also led the NFL by completing 72% of his passes and with a 113.5 passer rating. The only player to exceed both those marks in the same season was Drew Brees in 2018 and '19.
Buffalo's James Cook edged out Baltimore's Derrick Henry for the rushing title with 1,621 yards to Henry's 1,595. Henry had his record-setting fourth season with at least 1,500 yards rushing and 15 TD runs, including back-to-back campaigns in his 30s. No other player has done that even once after turning 30.
Jaxon Smith-Njigba set a Seattle record and led the NFL with 1,793 yards receiving.
Arizona's Trey McBride finished with 126 catches, the most ever for a tight end and three shy of Puka Nacua's league-leading total this season.
Houston's Ka’imi Fairbairn tied the record set by David Akers for San Francisco in 2011 when he made 44 field goals.
The tweaks to the kickoff rule this season had the desired effect when it came to the rate of returns.
Moving the touchback spot from the 30 to the 35 led to significantly more returns as kicking teams opted against touchbacks. In all, 74.5% of kickoffs were returned this season, more than doubling the rate of 32.8% in 2024 in the first year of the so-called “dynamic kickoff.” It was the highest rate of returns since 2010 when it was at 80.1%.
The NFL changed the rules for kickoffs following a record-low 21.8% return rate in 2023, hoping to increase returns while limiting injuries.
While there were only six return touchdowns this season, there were 87 returns of at least 40 yards for the most in any season since 2010 with 114.
The average starting field position after kicks was 30.8 yards from the end zone, a slight increase from 2024 and more than 5 yards better than 2023. That helped contribute to the highest-scoring season in the NFL since 2020, when teams averaged 23 points per game, up from 21.8 in the last year before the rule change.
The Detroit Lions went from NFC North champions last season to the basement this season.
They still finished with a better record than any team in the NFC South.
Those two divisions provided quite a dichotomy this season with all four teams in the North finishing with winning records and all four teams in the South having losing marks. Carolina won the division with an 8-9 record, becoming the fifth team to make the postseason with a losing record in a non-strike shortened season in NFL history.
Two of those four previous teams won their postseason opener with Carolina (7-8-1) beating Arizona (11-5) in 2014 and Seattle (7-9) topping New Orleans (11-5) in 2010.
The Lions went 9-8 but missed the playoffs as the NFC North joined the 2023 AFC North as the only divisions in the Super Bowl era with every team finishing with a winning mark.
Detroit was the second last-place team to finish with a better record than a first-place team with Washington (8-8-1) doing it in 2022 when Tampa Bay (8-9) won the NFC South.
The Bears won the NFC North with an 11-6 mark despite losing four of six division games. The only other teams since the merger to have a losing record in division games and still finish first were the 2010 Kansas City Chiefs and San Francisco in 1971.
Inside the Numbers dives into NFL statistics, streaks and trends each week. For more Inside the Numbers, head here.
AP NFL: https://apnews.com/hub/NFL
Cleveland Browns defensive end Myles Garrett (95) celebrates with defensive end Adin Huntington (98) after sacking Cincinnati Bengals quarterback Joe Burrow to set an NFL record for sacks in the regular season during the second half of an NFL football game, Sunday, Jan. 4, 2026, in Cincinnati. (AP Photo/Joshua A. Bickel)
Chicago Bears quarterback Caleb Williams (18) throws a pass during the second half of an NFL football game against the Detroit Lions, Sunday, Jan. 4, 2026, in Chicago. (AP Photo/Nam Y. Huh)
New England Patriots quarterback Drake Maye celebrates after a touchdown scored by running back TreVeyon Henderson during the second half of an NFL football game against the Miami Dolphins in Foxborough, Mass., Sunday, Jan. 4, 2026. (AP Photo/Charles Krupa)
Los Angeles Rams quarterback Matthew Stafford (9) looks to pass during the first half of an NFL football game against the Arizona Cardinals, Sunday, Jan. 4, 2026, in Inglewood, Calif. (AP Photo/Jessie Alcheh)
